Analysts have recently made several notable adjustments to their ratings and price targets for Icon Public Limited Company (NASDAQ: ICLR), reflecting varying outlooks on the clinical research organization. These changes come amidst a complex evaluation of the company’s performance and market position.
Recent Rating Changes
On December 15, 2025, analysts at Barclays PLC increased their price target for Icon from $185.00 to $200.00, maintaining an “equal weight” rating on the stock. In contrast, Bank of America Corporation downgraded Icon from a “buy” rating to a “neutral” rating, setting a new price target of $195.00.
Earlier in December, the company’s rating was reaffirmed by analysts at Weiss Ratings, who maintained a “hold (c)” rating. This reaffirmation follows a similar decision on December 1, 2025, indicating a consistent, cautious approach from the firm regarding Icon’s stock.
In a prior evaluation on November 25, 2025, Zacks Research upgraded Icon from a “strong sell” to a “hold” rating, suggesting a potential stabilization in investor sentiment towards the company.
Price Target Adjustments
The fluctuations in price targets have been significant. On October 24, 2025, multiple firms including UBS Group AG and Robert W. Baird set new price targets for Icon at $220.00. Conversely, TD Cowen lowered its price target from $183.00 to $172.00, still maintaining a “hold” rating. Additionally, Barclays had previously reduced its price target from $190.00 to $185.00 earlier that month.
The overall pattern of ratings and price adjustments illustrates a mixed sentiment among analysts, with some seeing potential upside while others remain cautious.
Icon Public Limited Company, headquartered in Ireland, provides outsourced development and commercialization services across Europe, the United States, and internationally. The organization specializes in managing various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.
These recent updates highlight the dynamic nature of the market and the varying outlooks from analysts as they assess the future performance of Icon. Investors may want to closely monitor these ratings as they could influence trading decisions in the upcoming months.
For those interested in following Icon and related market developments, subscribing to daily updates could provide valuable insights into further changes and analyst opinions.
